JCX-13-22 (June 24, 2022)

Estimated Revenue Effects Of The House Amendment To The Senate Amendment To H.R.4346, Scheduled For Consideration By The House Of Representatives On June 24, 2022 (Rules Committee Print 117-53)

The House or Representatives will consider Rules Committee Print 117-53 relating to the addition of vaccines against COVID-19 to the list of taxable vaccines.  The staff of the Joint Committee on Taxation has prepared an estimate of the budgetary effect of this legislation.


Related Publications

  • JCX-58-23 (December 05, 2023)

    Background On Cash-Flow And Consumption-Based Approaches To Taxation

    view details
  • JCX-34-23 (July 11, 2023)

    Macroeconomic Analysis Of H.R. 3938 The “Build It In America Act,” As Ordered To Be Reported By The Committee On Ways And Means, On June 13, 2023

    view details
  • JCX-32-23 (June 12, 2023)

    Description Of The Chairman’s Amendment In The Nature Of A Substitute To H.R. 3938, The “Build It In America Act”

    view details